Tender For Mri Conditional Dual Chamber Implantable Cardioverter Defibrillator System, Perambalur-Tamil Nadu

Supply Of Mri Conditional Dual Chamber Implantable Cardioverter Defibrillator Systemmri Conditional Dual Chamber Implantable Cardioverter Defibrillator System,Srph154064-Mri Conditional Dual Chamber Implantable Cardioverter Defibril Lator System With Appropriate Atrial And Ventricular Pace / Sense Leads And Option O F Dual Shocking Coil Leads And Accessories. System Should Have Advanced Features F Or The Reliable Detection And Management Of Ventricular Tachycardia And Ventricul Ar Fibrillation, Including Features To Differentiate Supra-Ventricular Tachycardia Fr Om Ventricular Tachycardia And Features To Avoid Inappropriate Shocks, Tiered Ther Apy Delivery, Choice Of Atp Protocols And Shock Energies, And Should Be Capable Of D Elivering Maximum Energy Of 35J Or More And Should Have Features For Management O F High Defibrillation Energy Requirement. Charge Times Should Be Within Clinically Ac Ceptable Limits Throughout The Lifetime Of The Device. Leads Should Be Low Profile An D Choice Of Both Active Or Passive Fixation Leads Should Be Available. Should Have Fea Tures For Automatically Alerting The Patient In The Event Of A Battery Or Lead Fault. Data Storage, Retrieval And Display Should Be Efficient And User Friendly. Data Stora Ge Should Include Episode Details, Therapy Delivered And Results And Electrogram St Orage And Should Be Comprehensive. Bradycardia Pacing (Including Independently Pr Ogrammable Parameters For High Output For Post-Shock Pacing) Should Be Available. Warranty Terms Should Be Specified Clearly Along With The Quotation. Firms Should S Ubmit Detailed Literature Of The Item In A Bulletin/Tutorial Format Which Should Conta In All The Details About The Product. Compliance Statement Of Each Specification To B E Submitted. The Firm Quoting The Tender Should Submit A Letter Of Authorisation Fro M The Principal Firm/Original Equipment Manufacturer. The Manufacturer / Supplier Sh Ould Submit Proof Of Supply To A Major Government Institute. The Safety And Efficac Y Of The Icd Device And The Lead In Clinical Use Should Be Documented In Scientific Publ Ications. All The Above Mentioned Specifications Are Essential And Mandatory And Sho Uld Be Submitted At The Time Of Initial Tender Submission. Unit: No

Refer document

INR 56300.0 /-

Refer document

Sl. No.	Item Description
1	Mri Conditional Dual Chamber Implantable Cardioverter Defibrillator System
2	SRPH154064-MRI CONDITIONAL DUAL CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRIL LATOR SYSTEM WITH APPROPRIATE ATRIAL AND VENTRICULAR PACE / SENSE LEADS AND OPTION O F DUAL SHOCKING COIL LEADS AND ACCESSORIES. SYSTEM SHOULD HAVE ADVANCED FEATURES F OR THE RELIABLE DETECTION AND MANAGEMENT OF VENTRICULAR TACHYCARDIA AND VENTRICUL AR FIBRILLATION, INCLUDING FEATURES TO DIFFERENTIATE SUPRA-VENTRICULAR TACHYCARDIA FR OM VENTRICULAR TACHYCARDIA AND FEATURES TO AVOID INAPPROPRIATE SHOCKS, TIERED THER APY DELIVERY, CHOICE OF ATP PROTOCOLS AND SHOCK ENERGIES, AND SHOULD BE CAPABLE OF D ELIVERING MAXIMUM ENERGY OF 35J OR MORE AND SHOULD HAVE FEATURES FOR MANAGEMENT O F HIGH DEFIBRILLATION ENERGY REQUIREMENT. CHARGE TIMES SHOULD BE WITHIN CLINICALLY AC CEPTABLE LIMITS THROUGHOUT THE LIFETIME OF THE DEVICE. LEADS SHOULD BE LOW PROFILE AN D CHOICE OF BOTH ACTIVE OR PASSIVE FIXATION LEADS SHOULD BE AVAILABLE. SHOULD HAVE FEA TURES FOR AUTOMATICALLY ALERTING THE PATIENT IN THE EVENT OF A BATTERY OR LEAD FAULT. DATA STORAGE, RETRIEVAL AND DISPLAY SHOULD BE EFFICIENT AND USER FRIENDLY. DATA STORA GE SHOULD INCLUDE EPISODE DETAILS, THERAPY DELIVERED AND RESULTS AND ELECTROGRAM ST ORAGE AND SHOULD BE COMPREHENSIVE. BRADYCARDIA PACING (INCLUDING INDEPENDENTLY PR OGRAMMABLE PARAMETERS FOR HIGH OUTPUT FOR POST-SHOCK PACING) SHOULD BE AVAILABLE. WARRANTY TERMS SHOULD BE SPECIFIED CLEARLY ALONG WITH THE QUOTATION. FIRMS SHOULD S UBMIT DETAILED LITERATURE OF THE ITEM IN A BULLETIN/TUTORIAL FORMAT WHICH SHOULD CONTA IN ALL THE DETAILS ABOUT THE PRODUCT. COMPLIANCE STATEMENT OF EACH SPECIFICATION TO B E SUBMITTED. THE FIRM QUOTING THE TENDER SHOULD SUBMIT A LETTER OF AUTHORISATION FRO M THE PRINCIPAL FIRM/ORIGINAL EQUIPMENT MANUFACTURER. THE MANUFACTURER / SUPPLIER SH OULD SUBMIT PROOF OF SUPPLY TO A MAJOR GOVERNMENT INSTITUTE. THE SAFETY AND EFFICAC Y OF THE ICD DEVICE AND THE LEAD IN CLINICAL USE SHOULD BE DOCUMENTED IN SCIENTIFIC PUBL ICATIONS. ALL THE ABOVE MENTIONED SPECIFICATIONS ARE ESSENTIAL AND MANDATORY AND SHO ULD BE SUBMITTED AT THE TIME OF INITIAL TENDER SUBMISSION. UNIT: NO